Figure 6
From: Clinical prognostic value of OSGIN2 in gastric cancer and its proliferative effect in vitro
Mutation information of OSGIN2 in gastric cancer (A,B) Mutation frequency and mutation type of OSGIN2 in gastric cancer, assessed using the cBioPortal database. (C) Specific sites where OSGIN2 is mutated and specific sites of phosphorylation and ubiquitination in GC patients. (D,E) Mutation types of OSGIN2 assessed in the COSMIC database.
